Inhibikase Therapeutics Inc (NAS:IKT)
$ 1.22 0.0597 (5.15%) Market Cap: 9.11 Mil Enterprise Value: 926,000.00 PE Ratio: 0 PB Ratio: 1.72 GF Score: 41/100